Bright Minds Biosciences (DRUG) had the highest return in 2024 by a small-cap US stock, returning 2,317.4%.

ASSET	YEAR	% RETURN
Bright Minds Biosciences (DRUG)	2024	2,317.45%
Palladyne AI (PDYN)	2024	1,541.69%
Red Cat (RCAT)	2024	1,343.82%
Power Solutions International, Inc Common Stock (PSIX)	2024	1,337.2%
Monopar Therapeutics (MNPR)	2024	1,229.31%
Quantum (QMCO)	2024	670.29%
United States Antimony (UAMY)	2024	608%
Root (ROOT)	2024	596.64%
Nano Nuclear Energy Inc Common Stock (NNE)	2024	591.53%
POET Technologies (POET)	2024	489.11%
Candel Therapeutics (CADL)	2024	482.55%
TheRealReal (REAL)	2024	452.02%
SEALSQ (LAES)	2024	412.5%
Rezolute (RZLT)	2024	405.15%
Janux Therapeutics (JANX)	2024	401.31%
BTQ Technologies Corp Common Stock (BTQ)	2024	358.33%
Willis Lease Finance (WLFC)	2024	349.75%
Eos Energy Enterprises (EOSE)	2024	337.84%
Unusual Machines (UMAC)	2024	320.5%
Benitec Biopharma Ltd ADR (BNTC)	2024	293.46%
Grupo Supervielle (SUPV)	2024	283.3%
IperionX Limited American Depositary Share (IPX)	2024	265.96%
Allot Communications (ALLT)	2024	260.61%
Priority Technology (PRTH)	2024	231.92%
Arqit Quantum (ARQQ)	2024	220.33%

Small-cap stocks are treated as having a market cap between $300M and $2B.